IN2012DE00337A - - Google Patents
Info
- Publication number
- IN2012DE00337A IN2012DE00337A IN337DE2012A IN2012DE00337A IN 2012DE00337 A IN2012DE00337 A IN 2012DE00337A IN 337DE2012 A IN337DE2012 A IN 337DE2012A IN 2012DE00337 A IN2012DE00337 A IN 2012DE00337A
- Authority
- IN
- India
- Prior art keywords
- addition
- hydrolysis
- organic solvent
- solution
- required quantity
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 230000007062 hydrolysis Effects 0.000 abstract 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008215 water for injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN337DE2012 IN2012DE00337A (enExample) | 2012-02-06 | 2012-03-29 | |
| EP12719066.8A EP2811984B1 (en) | 2012-02-06 | 2012-03-29 | Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| US14/377,047 US9872873B2 (en) | 2012-02-06 | 2012-03-29 | Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| PCT/IB2012/051513 WO2013117969A1 (en) | 2012-02-06 | 2012-03-29 | Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN337DE2012 IN2012DE00337A (enExample) | 2012-02-06 | 2012-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DE00337A true IN2012DE00337A (enExample) | 2015-04-10 |
Family
ID=46028019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN337DE2012 IN2012DE00337A (enExample) | 2012-02-06 | 2012-03-29 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9872873B2 (enExample) |
| EP (1) | EP2811984B1 (enExample) |
| IN (1) | IN2012DE00337A (enExample) |
| WO (1) | WO2013117969A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| HUE042327T2 (hu) | 2011-08-30 | 2019-06-28 | Astex Pharmaceuticals Inc | Decitabin-származék készítmények |
| US9801859B2 (en) * | 2012-09-18 | 2017-10-31 | Innopharma Licensing, Llc | Bendamustine formulations |
| US9765108B2 (en) | 2012-11-19 | 2017-09-19 | Shilpa Medicare Limited | Formulation of 5-azacytidine |
| CN109953954A (zh) | 2013-08-27 | 2019-07-02 | V·沃道里斯 | 苯达莫司汀医药组合物 |
| CN103585168A (zh) * | 2013-11-27 | 2014-02-19 | 哈尔滨誉衡药业股份有限公司 | 一种含有盐酸吉西他滨的药物组合物 |
| CN104739778A (zh) * | 2013-12-26 | 2015-07-01 | 山东新时代药业有限公司 | 一种注射用阿扎胞苷及其制备方法 |
| CA2941632C (en) * | 2014-03-13 | 2023-10-24 | Vasilios VOUDOURIS | Bendamustine solid dispersions and continuous infusion |
| US20160095925A1 (en) * | 2014-10-01 | 2016-04-07 | Cadila Healthcare Limited | Stable formulation of azacitidine or salts thereof and their process for preparation |
| WO2017004538A1 (en) * | 2015-07-02 | 2017-01-05 | Otsuka Pharmaceutical Co., Ltd. | Lyophilized pharmaceutical compositions |
| CN105769775A (zh) * | 2016-03-24 | 2016-07-20 | 浙江华海药业股份有限公司 | 一种注射用阿扎胞苷的制备方法 |
| BR112020002280A2 (pt) | 2017-08-03 | 2020-07-28 | Otsuka Pharmaceutical Co., Ltd. | composto farmacológico e métodos purificação do mesmo |
| CN108295034A (zh) * | 2018-03-29 | 2018-07-20 | 健进制药有限公司 | 一种注射用阿扎胞苷冻干粉针及其制备方法 |
| KR20190136284A (ko) * | 2018-05-30 | 2019-12-10 | 주식회사 삼양바이오팜 | 안정한 아자시티딘-함유 약제학적 조성물의 제조방법 |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| LT4243797T (lt) | 2020-11-16 | 2026-06-10 | Orcosa Inc. | Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684630A (en) | 1983-08-24 | 1987-08-04 | Repta Arnold J | Method of parenterally delivering drugs and related compositions |
| KR20060052880A (ko) | 2003-07-25 | 2006-05-19 | 와이어쓰 | 동결건조된 ｃｃｉ- 779 제형 |
| US20060069060A1 (en) * | 2004-09-27 | 2006-03-30 | Sanjeev Redkar | Salts of decitabine |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| CN101361718B (zh) | 2008-09-26 | 2013-08-28 | 深圳万乐药业有限公司 | 稳定的地西他滨冻干制剂的制备方法 |
| CN101584670B (zh) | 2009-06-19 | 2011-04-20 | 江苏奥赛康药业有限公司 | 地西他滨冻干粉针剂 |
| US20110042247A1 (en) | 2009-06-25 | 2011-02-24 | Chandrasekhar Kocherlakota | Formulations of azacitidine and its derivatives |
| WO2011014541A1 (en) | 2009-07-30 | 2011-02-03 | Eagle Pharmaceuticals, Inc. | Stable formulations of azacitidine |
| WO2011103150A2 (en) * | 2010-02-18 | 2011-08-25 | Cephalon, Inc. | Lyophilized preparations of bendamustine |
| EP2667868A4 (en) * | 2011-01-25 | 2014-12-10 | Reddys Lab Ltd Dr | Benda MUSTIN FORMULATIONS |
-
2012
- 2012-03-29 IN IN337DE2012 patent/IN2012DE00337A/en unknown
- 2012-03-29 WO PCT/IB2012/051513 patent/WO2013117969A1/en not_active Ceased
- 2012-03-29 EP EP12719066.8A patent/EP2811984B1/en active Active
- 2012-03-29 US US14/377,047 patent/US9872873B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9872873B2 (en) | 2018-01-23 |
| EP2811984B1 (en) | 2015-08-26 |
| EP2811984A1 (en) | 2014-12-17 |
| US20140378407A1 (en) | 2014-12-25 |
| WO2013117969A1 (en) | 2013-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA37400A1 (fr) | Composés hétérocyclyle en tant qu'inhibiteurs de mek | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| BR112019024747A2 (pt) | formulações de dose fixa | |
| EA201391758A1 (ru) | Спрессованная сердцевина для фармацевтической композиции, содержащая органические кислоты | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| BR112013013950A2 (pt) | antagonista de lpa1 policíclico e usos dos mesmos | |
| NZ729443A (en) | Heterocyclic modulators of lipid synthesis | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| IN2014DN03206A (enExample) | ||
| IN2014MN02652A (enExample) | ||
| MD20140136A2 (ro) | Inhibitori ai virusului hepatic C | |
| BR112013003439A2 (pt) | "inibidores de oxadiazol de produção de leucotrieno" | |
| BR112013004662B8 (pt) | Composto, composição farmacêutica, usos de um composto, e método para preparar uma composição farmacêutica | |
| MY179605A (en) | Use of benzimidazole-proline derivatives | |
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| EA032951B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| EA201891804A1 (ru) | Тетрациклиновые соединения | |
| PH12015502717A1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| BR112015030431A2 (pt) | formulação de liberação modificada | |
| UA117154C2 (uk) | Антагоністи s1p3 | |
| IN2013DN02555A (enExample) | ||
| BR112015018200A2 (pt) | composição mastigável para administração oral e processo para preparar a mesma | |
| EA201490573A1 (ru) | Соединение бензотиазолона | |
| MY169215A (en) | 3-o-heteroaryl-ingenol | |
| CL2015001881A1 (es) | Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición. |